Search results
Results From The WOW.Com Content Network
The current report notes that given a rapidly aging global population, the number of people with dementia is expected to almost triple by 2050, rising from 57 million in 2019 to 153 million.
Research at King's College London explored the hazards of suboptimal prescribing and polypharmacy in medicines use for people with dementia. They determined that each year there are globally up to 10 million people living with dementia require hospital treatment (emergency department or hospital admissions) related to medicines related harm for ...
Posterior cortical atrophy ( PCA ), also called Benson's syndrome, is a rare form of dementia which is considered a visual variant or an atypical variant of Alzheimer's disease (AD). [ 1][ 2][ 3] The disease causes atrophy of the posterior part of the cerebral cortex, resulting in the progressive disruption of complex visual processing. [ 4]
From the age of 60 years (10%) to the age of 80 years (60%), the proportion of people with senile plaques increases linearly. Women are slightly more likely to have plaques than are men. [ 45 ] [ 44 ] Both plaques and Alzheimer's disease also are more common in aging persons with trisomy -21 ( Down syndrome ).
“The APOE-e4 allele is the most important for Alzheimer’s disease risk,” she continued.“About 25% of people in the U.S. have at least one APOE-e4 allele and about 5% have two copies of it ...
Ultimately, they draw close to the traditional 80% dementia estimate for people with Parkinson’s, if more slowly. This report found a 50% chance of dementia 15 years after diagnosis, with a 74% ...
In community samples, cutoff scores for likely dementia have ranged from 3.3 and above to 3.6 and above, while in patient samples the cutoff scores have ranged from 3.4 and above to 4.0 and above. [3] To improve the detection of dementia, the IQCODE can be used in combination with the Mini-Mental State Examination.
The benefit of Eisai and Biogen's Alzheimer's drug Leqembi in patients with early-stage Alzheimer's appears to increase with continued use with no new safety issues, according to three-year data ...